In 1901, a young German psychiatrist named Alois Alzheimer evaluated his new patient, a 51-year-old woman named Auguste Deter. Ms. Deter, whom we now know as Auguste D., was hospitalized in Frankfurt to manage the debilitating symptoms of her brain disease. Today, we know that she had developed the condition which another psychiatrist, Emil Kraepelin, would later name after Dr. Alzheimer. We also know, thanks to historical research that has located Alzheimer’s original case notes, that Ms. Deter’s disease affected not only her memory but also her behavior. Alzheimer described his patient as pathologically jealous, unable to carry out her homemaking duties, troubled by auditory hallucinations, and fearful of persecution by her neighbors. The challenges presented by Ms. Deter’s non-cognitive behavioral symptoms (NCBS) and memory difficulties resulted in institutional care until her death some five years later.
This article provides an overview of these challenging behaviors, with more specific comments about treatment in two subsequent articles addressing agitation and other challenging behaviors associated with Major Neurocognitive Disorders (the new term for dementia):
- Part II: Explore the use of antipsychotics to treat the challenging behavioral symptoms of Alzheimer's disease.
- Part III: Explore some of the non-antipsychotic treatment options to help manage the challenging behaviors of Alzheimer’s disease
Beginning with the early definition of dementia, and not remedied in the more recent definition of major neurocognitive disorder, clinicians have focused on diagnosing cognitive impairment but have paid relatively less attention to accompanying disturbances of mood, activity, and mental content. The major neurocognitive disorders are diagnosed when clinicians observe a patient to have acquired an impairment in cognitive abilities such as memory, executive function, language, complex attention, visuospatial function, and social cognition. The change in capacity must not be the result of a temporary medical disturbance that is causing confusion, and must be sufficient to interfere with daily functioning to such a degree that independence is compromised.
For many clinicians and caregivers, this focus seems misplaced, because it is in fact the challenging behaviors of cognitively impaired people that create most of the distress, difficulty, and even danger involved in their care. Many caregivers seek help from health care providers to assist them in managing the challenges posed by the behaviors that accompany cognitive decline. Apathy or depression, for example, can further deplete a patient’s already limited quality of life. Agitation and aggression can endanger both patient and caregivers. Inappropriate sexual behaviors, which can frighten or harm others, can make it difficult for a cognitively impaired person to get along with others at home or in long-term care settings. Sleep disturbances can tax the endurance of caregivers beyond tolerance. Yet there are no widely standardized treatment approaches for addressing these behaviors, and no FDA-indicated medications for treatment them.
Early Signs and Symptoms
Behavioral symptoms not only accompany cognitive impairment in Alzheimer’s disease (AD), but in some cases even precede them. Social withdrawal, depression, anxiety, suicidal ideation, and mood changes have been shown to precede the onset of severe cognitive changes in AD by as much as several years. Over the course of the illness, more than 90% of AD patients will demonstrate challenging behavioral changes.
Common Behavioral Changes
The most common of these changes is apathy, a loss of motivation and initiative. The apathetic person appears emotionally indifferent or even depressed. Apathy shares with depression the features of low energy and interest, poor self-care, and diminished activity. Apathy differs importantly from depression in that sad mood, tearfulness, self-deprecating feelings, and suicidal thoughts or behaviors are less often present in apathy than in depression. Though less frequent than apathy, depression often complicates the course of a major neurocognitive impairment. Behavioral and medication treatments of apathy and depression, along with treatments for other challenging behaviors, will be addressed in a subsequent article.
Agitation has been defined by Dr. Cohen-Mansfield, a psychologist who has studied it thoroughly, as “inappropriate verbal, vocal or motor activity that is not judged by an outside observer to be an obvious outcome of the needs or confusion of the individual.” Aggression may accompany agitation, threatening a dangerous situation for frail older adults with AD or for those in their vicinity. In long-term care facilities, some 5% of residents are physically aggressive each year, resulting in thousands of assaults, some of which are lethal.
Inappropriate Sexual Behavior
Sexual behavior that is not appropriate to a person’s circumstances is often an inarticulately expressed request for closeness or comfort. Such inappropriate sexual behavior is a less frequent complication of AD, but is regarded as particularly disruptive because of the distress it may cause in others. Inappropriate touching of others or oneself while in public places can make a person with AD unwelcome among others including caregivers, long-term care residents, and even children with whom the affected person may interact.
Sleep disturbances affect more than half of severely demented AD patients. The part of the brain which helps us tell day from night is compromised early in the course of the disease, so sleep problems occur early and represent one of the most difficult issues for caregivers. The AD patient sleeps chaotically, dozing during the day and wandering at night. Changes in the sleep-wake cycle may contribute to the increased confusion, called sundowning, which often occurs in the later afternoons.
As a general principle, each of these challenging behaviors responds fairly well to behavioral and environmental interventions. Medications may provide additional help. The risks and complications of medications, particularly given the frailty and sensitivity of the older adults who may take them, has led to an emphasis on non-medication approaches to management. Both non-medication and medication approaches to agitation, and to other challenging behaviors associated with AD will be discussed in later articles in this series.
This content was last updated on: November 10, 2020
The information provided here is a public service of the BrightFocus Foundation and should not in any way substitute for personalized advice of a qualified healthcare professional; it is not intended to constitute medical advice. Please consult your physician for personalized medical advice. BrightFocus Foundation does not endorse any medical product, therapy, or resources mentioned or listed in this article. All medications and supplements should only be taken under medical supervision. Also, although we make every effort to keep the medical information on our website updated, we cannot guarantee that the posted information reflects the most up-to-date research.
These articles do not imply an endorsement of BrightFocus by the author or their institution, nor do they imply an endorsement of the institution or author by BrightFocus.
Some of the content may be adapted from other sources, which will be clearly identified within the article.